This finding aligns with recent studies demonstrating the role of Kras signaling in immune evasion [54], providing new mechanistic insights into how oncogenic signaling pathways may contribute to microenvironment remodeling in AML. The gene discussed is KRAS; the disease is acute myeloid leukemia.